Patients expect transparency in doctors’ relationships with the pharmaceutical industry

Catherine H Cole
Med J Aust 2009; 190 (8): . || doi: 10.5694/j.1326-5377.2009.tb02505.x
Published online: 20 April 2009

To the Editor: Two articles in the 19 January issue of the Journal1,2 and an article on the involvement of pharmaceutical companies in studies of their own products published in The Australian on the same day3 impel me to relate my own experience of attempting to influence my colleagues’ attitudes toward transparency in relationships with the pharmaceutical industry, and my good fortune to be working in a 21st century oncology clinical trials unit.

  • Catherine H Cole

  • University of Western Australia, Princess Margaret Hospital for Children, Perth, WA.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.